Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001856203 | SCV002237899 | pathogenic | Long QT syndrome | 2021-12-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects CACNA1C function (PMID: 23677916). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 633643). This missense change has been observed in individuals with long QT syndrome (PMID: 23677916, 32161207; Invitae). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs750835733, gnomAD 0.003%). This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 857 of the CACNA1C protein (p.Pro857Arg). |
OMIM | RCV000782177 | SCV000920645 | pathogenic | Long qt syndrome 8 | 2019-06-05 | no assertion criteria provided | literature only |